ADA2 and malaria: Our previous studies demonstrated that provisioning of young (3–5-day-old) female A. stephensi with the PanK activating pantazine drug PZ-2891 significantly reduced Pan availability in adult mosquitoes, thereby reducing infection success of diverse malaria parasite species in A. stephensi [6, 13].